nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Ifosfamide—testicular cancer	0.17	0.289	CbGbCtD
Metronidazole—CYP2C9—Ifosfamide—testicular cancer	0.119	0.201	CbGbCtD
Metronidazole—CYP2C8—Etoposide—testicular cancer	0.0813	0.138	CbGbCtD
Metronidazole—CYP3A4—Ifosfamide—testicular cancer	0.069	0.117	CbGbCtD
Metronidazole—CYP2C9—Cisplatin—testicular cancer	0.0577	0.098	CbGbCtD
Metronidazole—CYP3A4—Vinblastine—testicular cancer	0.0366	0.0622	CbGbCtD
Metronidazole—CYP3A4—Etoposide—testicular cancer	0.033	0.056	CbGbCtD
Metronidazole—CYP3A4—Doxorubicin—testicular cancer	0.0225	0.0382	CbGbCtD
Metronidazole—Gastrointestinal disorder—Etoposide—testicular cancer	0.000289	0.000703	CcSEcCtD
Metronidazole—Body temperature increased—Cisplatin—testicular cancer	0.000289	0.000702	CcSEcCtD
Metronidazole—Fatigue—Etoposide—testicular cancer	0.000288	0.000702	CcSEcCtD
Metronidazole—Neuropathy peripheral—Epirubicin—testicular cancer	0.000288	0.000701	CcSEcCtD
Metronidazole—Jaundice—Epirubicin—testicular cancer	0.000286	0.000697	CcSEcCtD
Metronidazole—Stomatitis—Epirubicin—testicular cancer	0.000286	0.000697	CcSEcCtD
Metronidazole—Constipation—Etoposide—testicular cancer	0.000286	0.000696	CcSEcCtD
Metronidazole—Pain—Etoposide—testicular cancer	0.000286	0.000696	CcSEcCtD
Metronidazole—Conjunctivitis—Epirubicin—testicular cancer	0.000286	0.000695	CcSEcCtD
Metronidazole—Urinary tract infection—Epirubicin—testicular cancer	0.000286	0.000695	CcSEcCtD
Metronidazole—Dysuria—Doxorubicin—testicular cancer	0.000285	0.000694	CcSEcCtD
Metronidazole—Neutropenia—Doxorubicin—testicular cancer	0.000285	0.000694	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000283	0.00069	CcSEcCtD
Metronidazole—Hepatitis—Methotrexate—testicular cancer	0.000282	0.000686	CcSEcCtD
Metronidazole—Sweating—Epirubicin—testicular cancer	0.000282	0.000686	CcSEcCtD
Metronidazole—Pollakiuria—Doxorubicin—testicular cancer	0.000282	0.000686	CcSEcCtD
Metronidazole—Dizziness—Ifosfamide—testicular cancer	0.00028	0.000681	CcSEcCtD
Metronidazole—Pharyngitis—Methotrexate—testicular cancer	0.00028	0.000681	CcSEcCtD
Metronidazole—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000278	0.000678	CcSEcCtD
Metronidazole—Hepatobiliary disease—Epirubicin—testicular cancer	0.000278	0.000677	CcSEcCtD
Metronidazole—Sinusitis—Epirubicin—testicular cancer	0.000276	0.000671	CcSEcCtD
Metronidazole—Feeling abnormal—Etoposide—testicular cancer	0.000276	0.000671	CcSEcCtD
Metronidazole—Nausea—Dactinomycin—testicular cancer	0.000274	0.000668	CcSEcCtD
Metronidazole—Agranulocytosis—Epirubicin—testicular cancer	0.000274	0.000668	CcSEcCtD
Metronidazole—Gastrointestinal pain—Etoposide—testicular cancer	0.000273	0.000666	CcSEcCtD
Metronidazole—Infestation NOS—Doxorubicin—testicular cancer	0.000272	0.000662	CcSEcCtD
Metronidazole—Drowsiness—Doxorubicin—testicular cancer	0.000272	0.000662	CcSEcCtD
Metronidazole—Infestation—Doxorubicin—testicular cancer	0.000272	0.000662	CcSEcCtD
Metronidazole—Visual impairment—Methotrexate—testicular cancer	0.000272	0.000661	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00027	0.000656	CcSEcCtD
Metronidazole—Vomiting—Ifosfamide—testicular cancer	0.000269	0.000655	CcSEcCtD
Metronidazole—Hypersensitivity—Cisplatin—testicular cancer	0.000269	0.000655	CcSEcCtD
Metronidazole—Rash—Ifosfamide—testicular cancer	0.000267	0.00065	CcSEcCtD
Metronidazole—Dermatitis—Ifosfamide—testicular cancer	0.000267	0.000649	CcSEcCtD
Metronidazole—Erythema multiforme—Methotrexate—testicular cancer	0.000267	0.000649	CcSEcCtD
Metronidazole—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000267	0.000649	CcSEcCtD
Metronidazole—Urticaria—Etoposide—testicular cancer	0.000266	0.000647	CcSEcCtD
Metronidazole—Jaundice—Doxorubicin—testicular cancer	0.000265	0.000645	CcSEcCtD
Metronidazole—Stomatitis—Doxorubicin—testicular cancer	0.000265	0.000645	CcSEcCtD
Metronidazole—Rhinitis—Epirubicin—testicular cancer	0.000264	0.000644	CcSEcCtD
Metronidazole—Abdominal pain—Etoposide—testicular cancer	0.000264	0.000643	CcSEcCtD
Metronidazole—Body temperature increased—Etoposide—testicular cancer	0.000264	0.000643	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—testicular cancer	0.000264	0.000643	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—testicular cancer	0.000264	0.000643	CcSEcCtD
Metronidazole—Hepatitis—Epirubicin—testicular cancer	0.000264	0.000642	CcSEcCtD
Metronidazole—Eye disorder—Methotrexate—testicular cancer	0.000263	0.000641	CcSEcCtD
Metronidazole—Tinnitus—Methotrexate—testicular cancer	0.000263	0.00064	CcSEcCtD
Metronidazole—Hypoaesthesia—Epirubicin—testicular cancer	0.000262	0.000639	CcSEcCtD
Metronidazole—Asthenia—Cisplatin—testicular cancer	0.000262	0.000637	CcSEcCtD
Metronidazole—Pharyngitis—Epirubicin—testicular cancer	0.000262	0.000637	CcSEcCtD
Metronidazole—Cardiac disorder—Methotrexate—testicular cancer	0.000262	0.000637	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—testicular cancer	0.000261	0.000635	CcSEcCtD
Metronidazole—Connective tissue disorder—Epirubicin—testicular cancer	0.000259	0.000631	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000257	0.000626	CcSEcCtD
Metronidazole—Angiopathy—Methotrexate—testicular cancer	0.000256	0.000623	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—testicular cancer	0.000255	0.000621	CcSEcCtD
Metronidazole—Immune system disorder—Methotrexate—testicular cancer	0.000255	0.00062	CcSEcCtD
Metronidazole—Visual impairment—Epirubicin—testicular cancer	0.000254	0.000619	CcSEcCtD
Metronidazole—Mediastinal disorder—Methotrexate—testicular cancer	0.000254	0.000618	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—testicular cancer	0.000254	0.000618	CcSEcCtD
Metronidazole—Nausea—Ifosfamide—testicular cancer	0.000251	0.000612	CcSEcCtD
Metronidazole—Diarrhoea—Cisplatin—testicular cancer	0.00025	0.000608	CcSEcCtD
Metronidazole—Erythema multiforme—Epirubicin—testicular cancer	0.000249	0.000607	CcSEcCtD
Metronidazole—Mental disorder—Methotrexate—testicular cancer	0.000247	0.000601	CcSEcCtD
Metronidazole—Eye disorder—Epirubicin—testicular cancer	0.000247	0.0006	CcSEcCtD
Metronidazole—Hypersensitivity—Etoposide—testicular cancer	0.000246	0.0006	CcSEcCtD
Metronidazole—Tinnitus—Epirubicin—testicular cancer	0.000246	0.000599	CcSEcCtD
Metronidazole—Erythema—Methotrexate—testicular cancer	0.000245	0.000597	CcSEcCtD
Metronidazole—Flushing—Epirubicin—testicular cancer	0.000245	0.000596	CcSEcCtD
Metronidazole—Cardiac disorder—Epirubicin—testicular cancer	0.000245	0.000596	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—testicular cancer	0.000245	0.000596	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—testicular cancer	0.000244	0.000594	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—testicular cancer	0.000243	0.000591	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—testicular cancer	0.000242	0.00059	CcSEcCtD
Metronidazole—Dysgeusia—Methotrexate—testicular cancer	0.00024	0.000585	CcSEcCtD
Metronidazole—Asthenia—Etoposide—testicular cancer	0.00024	0.000584	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—testicular cancer	0.00024	0.000584	CcSEcCtD
Metronidazole—Angiopathy—Epirubicin—testicular cancer	0.000239	0.000583	CcSEcCtD
Metronidazole—Immune system disorder—Epirubicin—testicular cancer	0.000238	0.00058	CcSEcCtD
Metronidazole—Mediastinal disorder—Epirubicin—testicular cancer	0.000238	0.000579	CcSEcCtD
Metronidazole—Back pain—Methotrexate—testicular cancer	0.000237	0.000578	CcSEcCtD
Metronidazole—Pruritus—Etoposide—testicular cancer	0.000237	0.000576	CcSEcCtD
Metronidazole—Visual impairment—Doxorubicin—testicular cancer	0.000235	0.000573	CcSEcCtD
Metronidazole—Vomiting—Cisplatin—testicular cancer	0.000232	0.000565	CcSEcCtD
Metronidazole—Vision blurred—Methotrexate—testicular cancer	0.000231	0.000563	CcSEcCtD
Metronidazole—Mental disorder—Epirubicin—testicular cancer	0.000231	0.000563	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—testicular cancer	0.000231	0.000562	CcSEcCtD
Metronidazole—Rash—Cisplatin—testicular cancer	0.00023	0.00056	CcSEcCtD
Metronidazole—Dermatitis—Cisplatin—testicular cancer	0.00023	0.00056	CcSEcCtD
Metronidazole—Erythema—Epirubicin—testicular cancer	0.00023	0.000559	CcSEcCtD
Metronidazole—Diarrhoea—Etoposide—testicular cancer	0.000229	0.000557	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—testicular cancer	0.000228	0.000555	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—testicular cancer	0.000228	0.000554	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—testicular cancer	0.000227	0.000551	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—testicular cancer	0.000227	0.000551	CcSEcCtD
Metronidazole—Flatulence—Epirubicin—testicular cancer	0.000226	0.000551	CcSEcCtD
Metronidazole—Dysgeusia—Epirubicin—testicular cancer	0.000225	0.000547	CcSEcCtD
Metronidazole—Back pain—Epirubicin—testicular cancer	0.000222	0.000541	CcSEcCtD
Metronidazole—Angiopathy—Doxorubicin—testicular cancer	0.000221	0.000539	CcSEcCtD
Metronidazole—Malaise—Methotrexate—testicular cancer	0.000221	0.000539	CcSEcCtD
Metronidazole—Dizziness—Etoposide—testicular cancer	0.000221	0.000538	CcSEcCtD
Metronidazole—Muscle spasms—Epirubicin—testicular cancer	0.000221	0.000537	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—testicular cancer	0.00022	0.000537	CcSEcCtD
Metronidazole—Vertigo—Methotrexate—testicular cancer	0.00022	0.000537	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—testicular cancer	0.00022	0.000536	CcSEcCtD
Metronidazole—Leukopenia—Methotrexate—testicular cancer	0.00022	0.000535	CcSEcCtD
Metronidazole—Nausea—Cisplatin—testicular cancer	0.000217	0.000528	CcSEcCtD
Metronidazole—Vision blurred—Epirubicin—testicular cancer	0.000216	0.000527	CcSEcCtD
Metronidazole—Mental disorder—Doxorubicin—testicular cancer	0.000214	0.000521	CcSEcCtD
Metronidazole—Convulsion—Methotrexate—testicular cancer	0.000213	0.000518	CcSEcCtD
Metronidazole—Vomiting—Etoposide—testicular cancer	0.000213	0.000518	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—testicular cancer	0.000212	0.000517	CcSEcCtD
Metronidazole—Rash—Etoposide—testicular cancer	0.000211	0.000513	CcSEcCtD
Metronidazole—Dermatitis—Etoposide—testicular cancer	0.000211	0.000513	CcSEcCtD
Metronidazole—Headache—Etoposide—testicular cancer	0.000209	0.00051	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—testicular cancer	0.000209	0.00051	CcSEcCtD
Metronidazole—Chest pain—Methotrexate—testicular cancer	0.000209	0.000509	CcSEcCtD
Metronidazole—Arthralgia—Methotrexate—testicular cancer	0.000209	0.000509	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—testicular cancer	0.000208	0.000507	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000207	0.000505	CcSEcCtD
Metronidazole—Malaise—Epirubicin—testicular cancer	0.000207	0.000504	CcSEcCtD
Metronidazole—Vertigo—Epirubicin—testicular cancer	0.000206	0.000502	CcSEcCtD
Metronidazole—Syncope—Epirubicin—testicular cancer	0.000206	0.000501	CcSEcCtD
Metronidazole—Leukopenia—Epirubicin—testicular cancer	0.000206	0.0005	CcSEcCtD
Metronidazole—Back pain—Doxorubicin—testicular cancer	0.000206	0.0005	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—testicular cancer	0.000204	0.000497	CcSEcCtD
Metronidazole—Palpitations—Epirubicin—testicular cancer	0.000203	0.000494	CcSEcCtD
Metronidazole—Confusional state—Methotrexate—testicular cancer	0.000202	0.000492	CcSEcCtD
Metronidazole—Loss of consciousness—Epirubicin—testicular cancer	0.000202	0.000491	CcSEcCtD
Metronidazole—Anaphylactic shock—Methotrexate—testicular cancer	0.0002	0.000488	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—testicular cancer	0.0002	0.000488	CcSEcCtD
Metronidazole—Convulsion—Epirubicin—testicular cancer	0.000199	0.000484	CcSEcCtD
Metronidazole—Infection—Methotrexate—testicular cancer	0.000199	0.000484	CcSEcCtD
Metronidazole—Nausea—Etoposide—testicular cancer	0.000199	0.000483	CcSEcCtD
Metronidazole—Hypertension—Epirubicin—testicular cancer	0.000198	0.000483	CcSEcCtD
Metronidazole—Nervous system disorder—Methotrexate—testicular cancer	0.000196	0.000478	CcSEcCtD
Metronidazole—Thrombocytopenia—Methotrexate—testicular cancer	0.000196	0.000477	CcSEcCtD
Metronidazole—Chest pain—Epirubicin—testicular cancer	0.000196	0.000476	CcSEcCtD
Metronidazole—Arthralgia—Epirubicin—testicular cancer	0.000196	0.000476	CcSEcCtD
Metronidazole—Skin disorder—Methotrexate—testicular cancer	0.000195	0.000474	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000194	0.000473	CcSEcCtD
Metronidazole—Hyperhidrosis—Methotrexate—testicular cancer	0.000194	0.000471	CcSEcCtD
Metronidazole—Malaise—Doxorubicin—testicular cancer	0.000192	0.000466	CcSEcCtD
Metronidazole—Dry mouth—Epirubicin—testicular cancer	0.000191	0.000465	CcSEcCtD
Metronidazole—Vertigo—Doxorubicin—testicular cancer	0.000191	0.000465	CcSEcCtD
Metronidazole—Anorexia—Methotrexate—testicular cancer	0.000191	0.000465	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—testicular cancer	0.000191	0.000464	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—testicular cancer	0.00019	0.000463	CcSEcCtD
Metronidazole—Confusional state—Epirubicin—testicular cancer	0.000189	0.00046	CcSEcCtD
Metronidazole—Palpitations—Doxorubicin—testicular cancer	0.000188	0.000457	CcSEcCtD
Metronidazole—Oedema—Epirubicin—testicular cancer	0.000187	0.000456	CcSEcCtD
Metronidazole—Anaphylactic shock—Epirubicin—testicular cancer	0.000187	0.000456	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—testicular cancer	0.000187	0.000455	CcSEcCtD
Metronidazole—Infection—Epirubicin—testicular cancer	0.000186	0.000453	CcSEcCtD
Metronidazole—Shock—Epirubicin—testicular cancer	0.000184	0.000449	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—testicular cancer	0.000184	0.000448	CcSEcCtD
Metronidazole—Nervous system disorder—Epirubicin—testicular cancer	0.000184	0.000447	CcSEcCtD
Metronidazole—Thrombocytopenia—Epirubicin—testicular cancer	0.000184	0.000447	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—testicular cancer	0.000183	0.000447	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000182	0.000444	CcSEcCtD
Metronidazole—Skin disorder—Epirubicin—testicular cancer	0.000182	0.000443	CcSEcCtD
Metronidazole—Hyperhidrosis—Epirubicin—testicular cancer	0.000181	0.000441	CcSEcCtD
Metronidazole—Insomnia—Methotrexate—testicular cancer	0.000181	0.000441	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—testicular cancer	0.000181	0.00044	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—testicular cancer	0.000181	0.00044	CcSEcCtD
Metronidazole—Paraesthesia—Methotrexate—testicular cancer	0.00018	0.000438	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00018	0.000437	CcSEcCtD
Metronidazole—Anorexia—Epirubicin—testicular cancer	0.000179	0.000435	CcSEcCtD
Metronidazole—Somnolence—Methotrexate—testicular cancer	0.000178	0.000433	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—testicular cancer	0.000177	0.000431	CcSEcCtD
Metronidazole—Dyspepsia—Methotrexate—testicular cancer	0.000176	0.000429	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—testicular cancer	0.000175	0.000426	CcSEcCtD
Metronidazole—Decreased appetite—Methotrexate—testicular cancer	0.000174	0.000424	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—testicular cancer	0.000173	0.000422	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—testicular cancer	0.000173	0.000422	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000173	0.000421	CcSEcCtD
Metronidazole—Fatigue—Methotrexate—testicular cancer	0.000173	0.00042	CcSEcCtD
Metronidazole—Infection—Doxorubicin—testicular cancer	0.000172	0.000419	CcSEcCtD
Metronidazole—Pain—Methotrexate—testicular cancer	0.000171	0.000417	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000171	0.000416	CcSEcCtD
Metronidazole—Shock—Doxorubicin—testicular cancer	0.000171	0.000415	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—testicular cancer	0.00017	0.000414	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—testicular cancer	0.00017	0.000413	CcSEcCtD
Metronidazole—Insomnia—Epirubicin—testicular cancer	0.00017	0.000413	CcSEcCtD
Metronidazole—Skin disorder—Doxorubicin—testicular cancer	0.000168	0.00041	CcSEcCtD
Metronidazole—Paraesthesia—Epirubicin—testicular cancer	0.000168	0.00041	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—testicular cancer	0.000168	0.000408	CcSEcCtD
Metronidazole—Somnolence—Epirubicin—testicular cancer	0.000167	0.000406	CcSEcCtD
Metronidazole—Anorexia—Doxorubicin—testicular cancer	0.000165	0.000402	CcSEcCtD
Metronidazole—Feeling abnormal—Methotrexate—testicular cancer	0.000165	0.000402	CcSEcCtD
Metronidazole—Dyspepsia—Epirubicin—testicular cancer	0.000165	0.000402	CcSEcCtD
Metronidazole—Gastrointestinal pain—Methotrexate—testicular cancer	0.000164	0.000399	CcSEcCtD
Metronidazole—Decreased appetite—Epirubicin—testicular cancer	0.000163	0.000397	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000162	0.000394	CcSEcCtD
Metronidazole—Fatigue—Epirubicin—testicular cancer	0.000162	0.000393	CcSEcCtD
Metronidazole—Pain—Epirubicin—testicular cancer	0.00016	0.00039	CcSEcCtD
Metronidazole—Constipation—Epirubicin—testicular cancer	0.00016	0.00039	CcSEcCtD
Metronidazole—Urticaria—Methotrexate—testicular cancer	0.000159	0.000387	CcSEcCtD
Metronidazole—Body temperature increased—Methotrexate—testicular cancer	0.000158	0.000385	CcSEcCtD
Metronidazole—Abdominal pain—Methotrexate—testicular cancer	0.000158	0.000385	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000158	0.000385	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—testicular cancer	0.000157	0.000382	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—testicular cancer	0.000156	0.000379	CcSEcCtD
Metronidazole—Feeling abnormal—Epirubicin—testicular cancer	0.000154	0.000376	CcSEcCtD
Metronidazole—Somnolence—Doxorubicin—testicular cancer	0.000154	0.000375	CcSEcCtD
Metronidazole—Gastrointestinal pain—Epirubicin—testicular cancer	0.000153	0.000373	CcSEcCtD
Metronidazole—Dyspepsia—Doxorubicin—testicular cancer	0.000153	0.000372	CcSEcCtD
Metronidazole—Decreased appetite—Doxorubicin—testicular cancer	0.000151	0.000367	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00015	0.000364	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—testicular cancer	0.00015	0.000364	CcSEcCtD
Metronidazole—Urticaria—Epirubicin—testicular cancer	0.000149	0.000362	CcSEcCtD
Metronidazole—Pain—Doxorubicin—testicular cancer	0.000148	0.000361	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—testicular cancer	0.000148	0.000361	CcSEcCtD
Metronidazole—Body temperature increased—Epirubicin—testicular cancer	0.000148	0.000361	CcSEcCtD
Metronidazole—Abdominal pain—Epirubicin—testicular cancer	0.000148	0.000361	CcSEcCtD
Metronidazole—Hypersensitivity—Methotrexate—testicular cancer	0.000148	0.000359	CcSEcCtD
Metronidazole—Asthenia—Methotrexate—testicular cancer	0.000144	0.00035	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—testicular cancer	0.000143	0.000348	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000142	0.000345	CcSEcCtD
Metronidazole—Pruritus—Methotrexate—testicular cancer	0.000142	0.000345	CcSEcCtD
Metronidazole—Hypersensitivity—Epirubicin—testicular cancer	0.000138	0.000336	CcSEcCtD
Metronidazole—Urticaria—Doxorubicin—testicular cancer	0.000138	0.000335	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—testicular cancer	0.000137	0.000334	CcSEcCtD
Metronidazole—Body temperature increased—Doxorubicin—testicular cancer	0.000137	0.000334	CcSEcCtD
Metronidazole—Diarrhoea—Methotrexate—testicular cancer	0.000137	0.000334	CcSEcCtD
Metronidazole—Asthenia—Epirubicin—testicular cancer	0.000134	0.000327	CcSEcCtD
Metronidazole—Pruritus—Epirubicin—testicular cancer	0.000133	0.000323	CcSEcCtD
Metronidazole—Dizziness—Methotrexate—testicular cancer	0.000132	0.000322	CcSEcCtD
Metronidazole—Diarrhoea—Epirubicin—testicular cancer	0.000128	0.000312	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—testicular cancer	0.000128	0.000311	CcSEcCtD
Metronidazole—Vomiting—Methotrexate—testicular cancer	0.000127	0.00031	CcSEcCtD
Metronidazole—Rash—Methotrexate—testicular cancer	0.000126	0.000307	CcSEcCtD
Metronidazole—Dermatitis—Methotrexate—testicular cancer	0.000126	0.000307	CcSEcCtD
Metronidazole—Headache—Methotrexate—testicular cancer	0.000125	0.000305	CcSEcCtD
Metronidazole—Asthenia—Doxorubicin—testicular cancer	0.000124	0.000303	CcSEcCtD
Metronidazole—Dizziness—Epirubicin—testicular cancer	0.000124	0.000302	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—testicular cancer	0.000123	0.000299	CcSEcCtD
Metronidazole—Vomiting—Epirubicin—testicular cancer	0.000119	0.00029	CcSEcCtD
Metronidazole—Nausea—Methotrexate—testicular cancer	0.000119	0.00029	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—testicular cancer	0.000119	0.000289	CcSEcCtD
Metronidazole—Rash—Epirubicin—testicular cancer	0.000118	0.000288	CcSEcCtD
Metronidazole—Dermatitis—Epirubicin—testicular cancer	0.000118	0.000287	CcSEcCtD
Metronidazole—Headache—Epirubicin—testicular cancer	0.000117	0.000286	CcSEcCtD
Metronidazole—Dizziness—Doxorubicin—testicular cancer	0.000115	0.000279	CcSEcCtD
Metronidazole—Nausea—Epirubicin—testicular cancer	0.000111	0.000271	CcSEcCtD
Metronidazole—Vomiting—Doxorubicin—testicular cancer	0.00011	0.000268	CcSEcCtD
Metronidazole—Rash—Doxorubicin—testicular cancer	0.000109	0.000266	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—testicular cancer	0.000109	0.000266	CcSEcCtD
Metronidazole—Headache—Doxorubicin—testicular cancer	0.000109	0.000264	CcSEcCtD
Metronidazole—Nausea—Doxorubicin—testicular cancer	0.000103	0.000251	CcSEcCtD
